Ad
related to: three phases of clinical trials
Search results
SOTIO Biotech doses first subject in Phase I solid tumour treatment trial
Clinical Trials Arena via Yahoo Finance· 8 hours agoSOTIO Biotech chief medical officer Richard Sachse...tumours. Synaffix’s ADC technology platform is...
Otsuka and Lundbeck report data from three PTSD treatment trials
Clinical Trials Arena via Yahoo Finance· 10 hours agoThe studies, encompassing a Phase II study (Trial 061) and two Phase III studies (Trial 071 and...
North Carolina clinical trial success leads to new breast cancer treatment
WXII-TV Winston-Salem· 1 day agoDonna Huie always heard people describe a cancer diagnosis as a "punch to the gut." An extra...
GeoVax to Present at BIO International Convention 2024
Digital Journal· 6 hours agoGeoVax's lead infectious disease candidate...
Where Will Amgen Be in 3 Years?
Motley Fool via Yahoo Finance· 7 hours agoFurthermore, its massive pipeline and deep pockets should provide multiple opportunities even if some of its clinical trials don't go as planned. Based...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 8 hours agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating ...
... Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in...
FOX 23 News Albany· 5 days ago...BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology...
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major...
Digital Journal· 1 day ago...include statements regarding the timing of and potential results from clinical trials; the potential efficacy, safety profile, future development plans in current and anticipated indications, addressable market, regulatory success and commercial potential of our and product candidates; the...
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 1 day agoFinnish biotechnology company TILT Biotherapeutics has announced results from a Phase I clinical ...
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
KFDX Wichita Falls· 2 days agoNS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase 3 ...
